News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current ALRN market cap is 25.11M. The company's latest EPS is USD -5.5939 and P/E is -0.88.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.48M | -4.7M | -5.01M | -1.99M | -1.98M |
| Net Income | -6.37M | -4.55M | -4.78M | -1.79M | -1.83M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31.9M | -29.96M | -20.5M | -26.61M | -27.65M |
| Net Income | -31.55M | -29.37M | -21.16M | -26.16M | -27.33M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 27.23M | 22.01M | 17.16M | 13.99M | 12.82M |
| Total Liabilities | 4.54M | 3.38M | 2.88M | 1.2M | 1.62M |
| Total Equity | 22.7M | 18.62M | 14.27M | 12.79M | 11.2M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 30.31M | 26.47M | 16.34M | 48.48M | 22.01M |
| Total Liabilities | 10.71M | 10.43M | 4.18M | 4.58M | 3.38M |
| Total Equity | 19.6M | 16.05M | 12.16M | 43.9M | 18.62M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.46M | -24.87M | -4.66M | -7.78M | -9.42M |
| Investing | 21.7M | 26.46M | 7.25M | 15.75M | 16.29M |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -27.93M | -26.47M | -20.48M | -23.75M | -24.87M |
| Investing | 24.69M | -2.81M | 6.41M | -35.92M | 26.46M |
| Financing | 2.52M | 23.96M | 15.8M | 55.66M | N/A |
| Market Cap | 25.11M |
| Price to Earnings Ratio | -0.88 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.66 |
| Price to Book Ratio | 1.3 |
| Dividend Yield | - |
| Shares Outstanding | 4.89M |
| Average Volume (1 week) | 60.61k |
| Average Volume (1 Month) | 49.16k |
| 52 Week Change | 217.28% |
| 52 Week High | 7.42 |
| 52 Week Low | 1.01 |
| Spread (Intraday) | 0.01 (0.2%) |
| Company Name | Aileron Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.aileronrx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
